You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tumor Necrosis Factor alpha inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer Trial (TILT-123, Pembrolizumab)

Not yet recruiting
  • Lung Cancer
  • TILT-123
  • Pembrolizumab
  • (no location specified)
Nov 5, 2023

STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in

Completed
  • Psoriatic Arthritis
  • No Intervention
  • Brussels, Belgium
  • +67 more
Jun 18, 2021

Rheumatoid Arthritis Trial in Canada, United States (ISIS 104838)

Completed
  • Rheumatoid Arthritis
  • ISIS 104838
  • Birmingham, Alabama
  • +30 more
Dec 1, 2022

Cardiac Functions in Type 1 Diabetes Mellitus

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • +2 more
  • transthoracic echocardiography
  • (no location specified)
Nov 12, 2023

Depressive Disorder, Major, Inflammation Trial (Infliximab, Placebo)

Not yet recruiting
  • Depressive Disorder, Major
  • Inflammation
  • (no location specified)
Nov 21, 2023

Acute Gout Trial in Nanchang (rhTNFR-Fc, Triamcinolone Acetonide)

Not yet recruiting
  • Acute Gout
  • Nanchang, Jiangxi, China
    Department of Rheumatology and Clinical Immunology, Jiangxi Prov
Jun 28, 2023

Salivary Interleukin-32, Interleukin-10, Interleukin-6 and Tumor

Completed
  • Early Childhood Caries
  • ELISA
  • Aydın, Turkey
    Sultan KELEŞ
Oct 20, 2021

Periimplant Soft Tissue Phenotype on Marginal Bone Loss

Completed
  • Alveolar Bone Loss
  • +2 more
  • Nuclear Factor-Kappa B Ligand (RANKL) analysis
  • +4 more
  • Konya, Turkey
    Necmettin Erbakan University, dentistry Faculty
Jan 24, 2023

IBD, Biological Substance; Adverse Effect Trial in Haifa (Azithromycin Pill, Placebo)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • Biological Substance; Adverse Effect
  • Azithromycin Pill
  • Placebo
  • Haifa, Israel
    Rambam Health Care Campus
Oct 25, 2022

HIV Trial in Honolulu, New York, Cleveland (Tumor Necrosis Factor soluble receptor-immunoadhesin complex)

Completed
  • HIV Infections
  • Tumor Necrosis Factor soluble receptor-immunoadhesin complex
  • Honolulu, Hawaii
  • +2 more
Oct 28, 2021

Tumor Necrosis Factor-alpha Antagonists in Rheumatoid Arthritis.

Recruiting
  • Rheumatoid Arthritis
  • +2 more
  • Infliximab: Adalimumab; Etanercept;
  • Sulaymaniyah, Kurdistan Region, Iraq
    Hiwa Khidhir Saaed
May 12, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 20, 2023

Aneurysm, Stroke, Vasculitis Trial in San Francisco (Infliximab)

Enrolling by invitation
  • Aneurysm
  • +3 more
  • San Francisco, California
    UCSF Medical Center
Apr 25, 2022

Solid Tumor Trial (Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T), Tumor necrosis factor-thymosin alfa 1 recombinant

Completed
  • Solid Tumor
  • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T)
  • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T) and chemotherapy
  • (no location specified)
Jun 8, 2023

Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate

Not yet recruiting
  • Pleural Effusion, Malignant
  • pleural markers
  • (no location specified)
Jan 20, 2023

Spinal Stenosis Trial (Epidural Intervention with TNF-a inhibitor)

Completed
  • Spinal Stenosis
  • Epidural Intervention with TNF-α inhibitor
  • (no location specified)
Aug 19, 2019

GCF PLAP-1, Sclerostin and TNF-a Levels in Periodontitis

Completed
  • Periodontitis
  • Periodontal clinical measurements and GCF sampling
  • Aydın, Turkey
    Adnan Menderes University, Faculty of Dentistry, Department of P
Dec 8, 2022

Immunogenicity of TNF Inhibitors in Arthritis Poorer Treatment

Recruiting
  • Arthritis, Rheumatoid
  • +2 more
    • Aalborg, Denmark
      Department of rheumatology
    Sep 1, 2022

    Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier

    Completed
    • Arthritis Rheumatoid
    • New York, New York
      Pfizer
    Jun 8, 2022

    HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive

    Recruiting
    • Drug Monitoring
    • Inflammatory Bowel Diseases
    • Tumor necrosis factor (TNF)-alpha inhibitors
    • Valladolid, Spain
      Hospital Universitario Rio Hortega
    Aug 8, 2023

    Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Thymalfasin, Radiotherapy, PD-1/PD-L1 inhibitor)

    Recruiting
    • Advanced Solid Tumor
    • Refractory Tumor
    • Suzhou, China
      The Second Affiliated Hospital of SchoowUniversity
    Mar 29, 2023

    Rheumatoid Arthritis Trial in Copenhagen (Exercise, No exercise)

    Recruiting
    • Rheumatoid Arthritis
    • Exercise
    • No exercise
    • Copenhagen, Denmark
      Rigshospitalet
    Feb 3, 2022

    Platinum-refractory Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial in Rochester, Helsinki (TILT-123, Pembrolizumab)

    Recruiting
    • Platinum-refractory Ovarian Carcinoma
    • Platinum-resistant Ovarian Cancer
    • TILT-123
    • Pembrolizumab
    • Rochester, Minnesota
    • +1 more
    Aug 12, 2022

    Colitis,Ulcerative Trial in Norway (Discontinuation of anti-TNF treatment, Continuation of anti-TNF treatment)

    Active, not recruiting
    • Colitis,Ulcerative
    • Discontinuation of anti-TNF treatment
    • Continuation of anti-TNF treatment
    • Alesund, Norway
    • +18 more
    Jul 13, 2022

    Therapeutic Drug Monitoring and Serum TNFa Levels in Pediatric

    Completed
    • Acute Graft-versus-host Disease
      • Trieste, Italy
        IRCCS Burlo Garofolo
      Apr 11, 2023